Examination of changes in nutritional status and body composition after SGLT2 inhibitor administration for patients with liver cirrhosis and with diabetes
Not Applicable
Recruiting
- Conditions
- on alcoholic fatty liver disease diabetes mellites
- Registration Number
- JPRN-UMIN000045412
- Lead Sponsor
- Saga University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Under 20 years old (2) Decompensated cirrhosis (Child-Pugh classification C) (3) Patients who are already taking SGLT2 inhibitors or who have been found to be allergic to SGLT2 inhibitors in the past (4) Patients using insulin preparations for diabetes treatment (5) Patients who are pregnant or may become pregnant (6) Other patients who the attending physician has determined to be unable to participate in the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in nutritional status due to SGLT2 inhibitor treatment in patients with liver cirrhosis
- Secondary Outcome Measures
Name Time Method Changes in body composition (water, fat mass, muscle mass) after 6 months Changes in liver hardness and liver reserve after 6 months